← FDA DRUG APPROVALS

FDA ANDA · ANDA088637

PROCAINAMIDE HYDROCHLORIDE

Sponsor: INTL MEDICATION

APPLICATION
ANDA088637
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-31
LATEST ACTION
1999-09-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 500MG/ML · INJECTABLE · INJECTION

Approval history

1999-09-22Labeling · Supplement 14AP
1998-01-14Manufacturing (CMC) · Supplement 11AP
1995-09-19Manufacturing (CMC) · Supplement 13AP
1994-06-17Manufacturing (CMC) · Supplement 12AP
1993-10-29Manufacturing (CMC) · Supplement 10AP
1992-11-02Labeling · Supplement 9AP
1992-06-10Labeling · Supplement 8AP
1992-03-13Labeling · Supplement 7AP
1990-01-05Labeling · Supplement 6AP
1987-09-10Manufacturing (CMC) · Supplement 5AP
1987-01-29Manufacturing (CMC) · Supplement 2AP
1984-07-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →